Martindale: The Complete Drug Reference

Martindale: The Complete Drug Reference provides unbiased and evaluated information on drugs and medicines in use around the world. It is prepared by an experienced team of pharmacists and life scientists who use their professional expertise to select the most clinically relevant and appropriate information from reliable published sources.

---

Martindale: The Complete Drug Reference provides unbiased and evaluated information on drugs and medicines in use around the world. It is prepared by an experienced team of pharmacists and life scientists who use their professional expertise to select the most clinically relevant and appropriate information from reliable published sources, to provide an unbiased and evaluated digest of the literature.

Includes:


Over 6,300 drug monographs (and over 7,500 online, accessible via a MedicinesComplete subscription)
Over 185,000 preparations (and over 270,000 online via MedicinesComplete)
Over 54,000 reference citations
Over 20,000 manufacturers and distributors
Proprietary preparations from 43 countries and regions
Nearly 700 treatment reviews, with references from the published literature
Enables identification of medicines, the local equivalent and the manufacturer
Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines


Sample PDF’s of each section will be available shortly before publication date at www.pharmpress.com/martindale39

Changes to this new edition:
More than 130 new monographs including:


Lumacaftor: a cystic fibrosis transmembrane conductance regulator (CFTR) protein corrector
Pitolisant: a central stimulant used in the treatment of narcolepsy
Rolapitant: a neurokinin-1 receptor antagonist that is used for the prevention of nausea and vomiting associated with cancer chemotherapy
Umeclidinium Bromide: a quaternary ammonium antimuscarinic used as a bronchodilator in the treatment of reversible airways obstruction

New Hepatitis C treatment table and drugs including ledipasvir, ombitasvir, paritaprevir, and dasabuvir
Coverage of proprietary preparations in 43 countries including Australia, China, UK, and USA, revised and updated